Our News

CN Bio and Imperial College London Collaboration

CN Bio and Imperial College London collaborate to identify novel treatments for alcoholic hepatitis. CN Bio’s Liver-on-Chip technology to define underlying disease mechanisms and screen therapeutic targets. CN Bio, a leading cell culture company, that has developed...

read more

NASH Drug Discovery Service Launched at AASLD

Leading bioengineering company CN Bio has launched a fee for service program providing Human Organ-on-Chip data to scientists studying non-alcoholic steatohepatitis (NASH) therapeutics. CN Bio launched the program at the American Association for the Study of Liver...

read more

CN Bio to bring 10 organs together on a chip

London Organ-­on-­Chip specialist CN Bio today announced it has secured an exclusive license to technology from the Massachusetts Institute of Technology for Organ-­on-­Chip systems which connect human tissues from up to 10 organs. CN Bio participated with MIT on a...

read more